Cargando…

Is serum PSA a predictor of male hypogonadism? Testing the hypothesis

OBJECTIVE: Male hypogonadism (MH) is common among infertile men. Besides testosterone, limited MH biomarkers are available, while researchers have suggested the use of prostate-specific antigen (PSA) to help diagnose MH. Hence, we sought to evaluate the potential use of PSA to predict MH among relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amadi, Collins, Green, Kinikanwo I., Odum, Ehimen P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065314/ https://www.ncbi.nlm.nih.gov/pubmed/33587836 http://dx.doi.org/10.20945/2359-3997000000326

Ejemplares similares

Is serum PSA a predictor of male hypogonadism?
Publicado: (2021)

Status of Serum Prolactin Levels among Male Cohort in Infertile Couples
por: Green, Kinikanwo I., et al.
Publicado: (2020)

The impact of plasma zinc status on the severity of prostate cancer disease
por: Wakwe, Victor C., et al.
Publicado: (2019)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

Male hypogonadism: Symptoms and treatment
por: Kumar, Peeyush, et al.
Publicado: (2010)

Hypogonadism in male cancer patients
por: Burney, Basil O., et al.
Publicado: (2012)

Substance Abuse and Male Hypogonadism
por: Duca, Ylenia, et al.
Publicado: (2019)

Editorial: Aging and male hypogonadism
por: Xia, Kai, et al.
Publicado: (2023)

Androgen Treatment in Adolescent Males With Hypogonadism
por: Rey, Rodolfo A., et al.
Publicado: (2020)

Male Hypogonadism and Disorders of Sex Development
por: Grinspon, Romina P., et al.
Publicado: (2020)

LPCN 1144 Resolves NAFLD in Hypogonadal Males
por: Albhaisi, Somaya, et al.
Publicado: (2020)

Serum testosterone levels in male hypogonadism: Why and when to check—A review
por: Livingston, Mark, et al.
Publicado: (2017)

Male Idiopathic Hypogonadotropic Hypogonadism: Serum Insulin-like Growth Factor-1 and Oestradiol Levels
por: Salehisedeh, Nastaran, et al.
Publicado: (2022)

A New Interpretation of the Standard PSA-Test
por: Esteban, Ernesto P, et al.
Publicado: (2020)

Establishment of reference intervals for serum [−2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men
por: Wu, Zhi-Yu, et al.
Publicado: (2019)

AB70. Controversies in male hypogonadism
por: Khera, Mohit
Publicado: (2014)

Approaches to male hypogonadism in primary care
por: Lawrence, Kristi L., et al.
Publicado: (2017)

Metabolic Disorders and Male Hypogonadotropic Hypogonadism
por: Pivonello, Rosario, et al.
Publicado: (2019)

Effect of exogenous glucocorticoids on male hypogonadism
por: Mohammed, Adel Gassab, et al.
Publicado: (2020)

Biomarkers of male hypogonadism in childhood and adolescence
por: Rey, Rodolfo A.
Publicado: (2020)

FRI433 Hypogonadism In Males With Adrenoleukodystrophy
por: Alcantara, Jonanlis Ramirez, et al.
Publicado: (2023)

New frontiers in fertility preservation: a hypothesis on fertility optimization in men with hypergonadotrophic hypogonadism
por: Herati, Amin S., et al.
Publicado: (2020)

Can Low SHBG Serum Concentration Be A Good Early Marker Of Male Hypogonadism In Metabolic Syndrome?
por: Jarecki, Piotr, et al.
Publicado: (2019)

Bilateral male breast cancer with male potential hypogonadism
por: Hirose, Yukiko, et al.
Publicado: (2007)

Association of Male Hypogonadism With Risk of Hospitalization for COVID-19
por: Dhindsa, Sandeep, et al.
Publicado: (2022)

Diagnosis of Male Central Hypogonadism During Childhood
por: Grinspon, Romina P, et al.
Publicado: (2021)

Predictors of reproductive and non-reproductive outcomes of gonadotropin mediated pubertal induction in male patients with congenital hypogonadotropic hypogonadism (CHH)
por: Cangiano, B., et al.
Publicado: (2021)

Androgen dynamics and serum PSA in patients treated with abiraterone acetate
por: Ryan, C J, et al.
Publicado: (2014)

Fasting times in serum PSA assay
por: Xu, Xiang, et al.
Publicado: (2014)

Predictors of PSA Screening Among Men Over 40 Years of Age Who Had Ever Heard about PSA
por: Seo, Hyung Seok, et al.
Publicado: (2010)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Male hypogonadism in a patient with Cogan syndrome
por: Radman, Maja, et al.
Publicado: (2008)

Predictors of Repeated PSA Testing Among Black and White Men From the Maryland Cancer Survey, 2006
por: Zhu, Yue, et al.
Publicado: (2011)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Metabolic patterns in insulin-resistant male hypogonadism
por: Gevi, Federica, et al.
Publicado: (2018)

Metabolic patterns in insulin-sensitive male hypogonadism
por: Fanelli, Giuseppina, et al.
Publicado: (2018)

Animal Models of Diabetes-Related Male Hypogonadism
por: Dimakopoulou, Anastasia, et al.
Publicado: (2019)

Treatment of congenital hypogonadotropic hypogonadism in male patients
por: Lee, Hae Sang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b6u0qf9oc9ej27bd6qs766gmnv